44.210.77.106
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Trending Topics

FDA grants Breakthrough Therapy designation for avacincaptad pegol for geographic atrophy

The U.S. Food and Drug Administration has granted Breakthrough Therapy designation for avacincaptad pegol (Zimura; Iveric Bio), a novel investigational complement C5 inhibitor for the treatment of geographic atrophy (GA) secondary to Age-Related Macular Degeneration (AMD). This is the first investigational therapy to receive Breakthrough Therapy designation status for GA...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-